CCA
ABBV icon

Clearwater Capital Advisors’s AbbVie ABBV Stock Holding History

Clearwater Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448K Buy
1,781
+50
+3% +$10.8K 0.03% 132
2026
Q1 		$376K Buy
1,731
+104
+6% +$23.1K 0.03% 131
2025
Q4 		$372K Sell
1,627
-51
-3% -$11.6K 0.03% 134
2025
Q3 		$389K Buy
1,678
+30
+2% +$6.11K 0.03% 126
2025
Q2 		$306K Hold
1,648
– – 0.03% 135
2025
Q1 		$345K Sell
1,648
-90
-5% -$17.5K 0.03% 133
2024
Q4 		$309K Sell
1,738
-57
-3% -$10.5K 0.03% 139
2024
Q3 		$354K Buy
1,795
+41
+2% +$7.65K 0.03% 129
2024
Q2 		$301K Buy
1,754
+16
+0.9% +$2.65K 0.03% 127
2024
Q1 		$316K Sell
1,738
-209
-11% -$36K 0.03% 127
2023
Q4 		$302K Buy
1,947
+88
+5% +$12.8K 0.03% 123
2023
Q3 		$277K Buy
1,859
+69
+4% +$10.1K 0.03% 115
2023
Q2 		$241K Buy
1,790
+41
+2% +$6.01K 0.03% 130
2023
Q1 		$279K Sell
1,749
-39
-2% -$5.96K 0.03% 119
2022
Q4 		$289K Hold
1,788
– – 0.04% 124
2022
Q3 		$240K Hold
1,788
– – 0.03% 137
2022
Q2 		$274K Buy
1,788
+39
+2% +$5.96K 0.04% 121
2022
Q1 		$284K Buy
+1,749
New +$254K 0.03% 137
2019
Q1 		– Sell
-2,607
Closed -$240K – 191
2018
Q4 		$240K Buy
2,607
+380
+17% +$33.4K 0.05% 181
2018
Q3 		$211K Buy
+2,227
New +$211K 0.04% 183
2018
Q2 		– Sell
-2,055
Closed -$195K – 182
2018
Q1 		$195K Buy
+2,055
New +$226K 0.04% 182
2017
Q4 		– Sell
-2,895
Closed -$263K – 176
2017
Q3 		$263K Buy
+2,895
New +$220K 0.06% 150

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Clearwater Capital Advisors's ABBV Position: Q2 2026 in Review

Clearwater Capital Advisors increased its AbbVie (ABBV) stake by 2.9% in Q2 2026, buying an estimated $10.8K and bringing the position to 1,781 shares worth $448K. The position accounts for 0.03% of the portfolio, ranked #132.

Clearwater Capital Advisors first reported a position in ABBV in Q3 2017 and has held it in 22 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Clearwater Capital Advisors held 1,781 shares of AbbVie worth $448K as of Q2 2026.
  • Clearwater Capital Advisors bought 50 AbbVie shares in Q2 2026, an estimated $10.8K.
  • AbbVie made up 0.03% of Clearwater Capital Advisors's portfolio in Q2 2026, its #132 holding.
  • Clearwater Capital Advisors first reported a position in AbbVie in Q3 2017 and has held it in 22 quarters since.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Clearwater Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.